Cargando…

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression

BACKGROUND: Bladder cancer (BlCa) taxonomy has proved its impact in patient outcome and selection for targeted therapies, but such transcriptomic-based classification has not yet translated to routine practice. Moreover, epithelial-to-mesenchymal transition (EMT) has shown relevance in acquisition o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobo, João, Monteiro-Reis, Sara, Guimarães-Teixeira, Catarina, Lopes, Paula, Carneiro, Isa, Jerónimo, Carmen, Henrique, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405371/ https://www.ncbi.nlm.nih.gov/pubmed/32758253 http://dx.doi.org/10.1186/s12967-020-02475-w

Ejemplares similares

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
por: Monteiro-Reis, Sara, et al.
Publicado: (2019)

Downregulation of m(6)A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness
por: Guimarães‐Teixeira, Catarina, et al.
Publicado: (2022)

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
por: Barros-Silva, Daniela, et al.
Publicado: (2020)

Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma
por: Petronilho, Sara, et al.
Publicado: (2021)

The Clinicopathological Significance of BiP/GRP-78 in Breast Cancer: A Meta-Analysis of Public Datasets and Immunohistochemical Detection
por: Direito, Inês, et al.
Publicado: (2022)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
por: Guseinova, D, et al.
Publicado: (2008)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas
por: Dao, Long, et al.
Publicado: (2021)

A Multiplex Test Assessing MiR663a(me) and VIM(me) in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
por: Amorim, Maria, et al.
Publicado: (2019)

Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2020)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
por: Dejaco, Christian, et al.
Publicado: (2006)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
por: Lin, Jiaying, et al.
Publicado: (2017)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021)

Extracellular Vesicles as Potential Bladder Cancer Biomarkers: Take It or Leave It?
por: Teixeira-Marques, Ana, et al.
Publicado: (2023)

Added value of lymphocyte subpopulations in the classification of Sjögren's syndrome
por: Barcelos, Filipe, et al.
Publicado: (2023)

Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm
por: Lourenço, Beatriz Chaves, et al.
Publicado: (2022)

MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop
por: Xu, Mingjie, et al.
Publicado: (2018)

Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer
por: Carneiro, Isa, et al.
Publicado: (2019)

Immunoexpression of N-cadherin, Twist and Vimentin in Bladder Urothelial Carcinomas
por: STEPAN, A.E., et al.
Publicado: (2015)

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
por: Dong, Qiongzhu, et al.
Publicado: (2016)

p53 mutations have no additional prognostic value over stage in bladder cancer.
por: Vet, J. A., et al.
Publicado: (1994)

Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
por: Carvalho, Ângela, et al.
Publicado: (2021)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
por: Nascimento, Marilda Savoia, et al.
Publicado: (2018)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
por: Meireles, Sara, et al.
Publicado: (2023)

Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
por: Viveiros, Nicole, et al.
Publicado: (2022)

Gal-3 Protein Expression and Localization in Prostate Tumours
por: Lima, Tânia, et al.
Publicado: (2023)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
por: Mansour, Howaida E., et al.
Publicado: (2010)

The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma
por: Niknami, Zohreh, et al.
Publicado: (2017)

The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer
por: Fang, Tianyi, et al.
Publicado: (2022)

Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
por: Martins-Lima, Cláudia, et al.
Publicado: (2023)

Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
por: Purwanto, Ibnu, et al.
Publicado: (2023)

Association of Cytokeratin and Vimentin Protein in the Genesis of Transitional Cell Carcinoma of Urinary Bladder Patients
por: Rahmani, Arshad H., et al.
Publicado: (2015)

Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs
por: Engbersen, Diederik J. M., et al.
Publicado: (2023)

Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers
por: Lobo, João, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a8fepnepmu8uqguj297dethqrg